Mainz Biomed BV (MYNZ) Key Ratios

$0.47

up-down-arrow $-0.37 (-43.85%)

As on 09-Apr-2026 09:30EDT

Market cap

info icon

$11 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

10.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -32.92 -39.92 0.45 1.70
EBIT -- 49.78 34.39 14.07 -298.59
Net Profit -- 25.98 25.13 11.53 -291.30
EPS -- 88.05 87.91 8.10 -354.07
Book Value -- -- -98.29 -62.03 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info -2,574.49-2,925.97-2,513.37-2,301.53-2,908.58
Net Margin info ----------
Return on equity info -417.93-431.67-484.76-465.82-303.20
Return on Capital info -221.08-223.90-258.73-216.64-187.86
Return on Assets info -157.77-173.25-174.63-151.15-147.52
Debt to Equity (x) info ----4.010.542.28
ROCE

-258.73

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-258.73
-216.64
-187.86
-201.45
-254.81
Peer Median
--
--
--
--
--
ROE

-484.76

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-484.76
-465.82
-303.20
-258.62
-645.93
Peer Median
--
--
--
--
--
ROA

-174.63

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-174.63
-151.15
-147.52
-174.71
-218.22
Peer Median
--
--
--
--
--
EBIT Margin

-2,513.37

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-2,513.37
-2,301.53
-2,908.58
-4,940.32
-1,966.05
Peer Median
--
--
--
--
--
Net Margin

-3,018.31

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-3,018.31
-2,421.80
-2,936.50
-4,992.24
-2,024.79
Peer Median
--
--
--
--
--
Revenue Growth

-0.40

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-0.40
0.00
0.69
-0.08
0.17
Peer Median
--
--
--
--
--
EBIT Growth

34.39

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
34.39
21.00
0.50
-130.62
-2,665.30
Peer Median
--
--
--
--
--
Net Profit Growth

25.13

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
25.13
17.66
0.59
-126.28
-1,891.86
Peer Median
--
--
--
--
--
EPS Growth

0.88

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
0.88
0.55
-12.55
-1.26
-63.69
Peer Median
--
--
--
--
--
Debt to Equity

4.01

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
4.01
0.54
2.28
0.23
0.41
Peer Median
--
--
--
--
--
Short term debt to equity ratio

2.46

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
2.46
0.40
1.61
0.09
0.04
Peer Median
--
--
--
--
--
Current Ratio

0.50

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
0.50
1.32
0.97
4.33
7.11
Peer Median
--
--
--
--
--
Quick Ratio

0.44

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
0.44
1.26
0.91
4.29
645.64
Peer Median
--
--
--
--
--
Interest Coverage

-36.15

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-36.15
-19.14
-32.17
-90.48
-33.47
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

20.65

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
20.65
23.91
39.59
48.91
3.08
Peer Median
--
--
--
--
--
Asset Turnover

0.06

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
0.06
0.06
0.05
0.03
0.11
Peer Median
--
--
--
--
--
Receivable days

110.39

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
110.39
116.08
125.15
95.43
19.61
Peer Median
--
--
--
--
--
Inventory Days

141.16

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
141.16
564.58
373.52
-453,227.34
-788,695.13
Peer Median
--
--
--
--
--
Payable days

401.93

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
401.93
2,049.19
1,732.19
1,137.35
469.64
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-150.39

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-150.39
-1,368.53
-1,233.52
-454,269.25
-789,145.15
Peer Median
--
--
--
--
--
Price / Earnings

-0.41

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-0.41
-0.19
-0.02
-1.94
-6.41
Peer Median
--
--
--
--
--
Price / Book Value

10.47

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
10.47
0.69
0.19
3.63
11.78
Peer Median
--
--
--
--
--
EV/EBITDA

-0.65

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Mainz Biomed BV (MYNZ)
-0.65
-0.06
-0.04
-1.45
-6.10
Peer Median
--
--
--
--
--
loading...
loading...